Trial Profile
Phase II trial of methanesulfonyl fluoride for the treatment of Alzheimer's disease.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 10 Jan 2011
Price :
$35
*
At a glance
- Drugs Methanesulfonyl fluoride (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Sponsors SeneXta Therapeutics
- 10 Jan 2011 New trial record